A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC.

Publication Year: 2024

DOI:
10.1186/s12935-024-03267-8

PMCID:
PMC10859031

PMID:
38341588

Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability the datasets generated and analyzed during the present study are available in the tcga repository ( https://portal gdc cancer gov/ ) and geo repository (gse42127) ( https://www ncbi nlm nih gov/ ). data availability the datasets generated and analyzed during the present study are available in the tcga repository ( https://portal gdc cancer gov/ ) and geo repository (gse42127"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis work was carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association. This study was approved by the Ethics Committee of the Affiliated Hospital of Nantong University (Nantong, Jiangsu, China) under no. 2022-L165. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (81770266), “Six-one” Project for High-level Health Talents (LGY2016037), National Natural Science Foundation of China (82370253), Jiangsu Provincial Research Hospital (YJXYY202204), Innovation Team Project of Affiliated Hospital of Nantong University (XNBHCX31773), Nantong Key Laboratory of Translational Medicine in Cardiothoracic Diseases, Nantong Clinical Medical Research Center of Cardiothoracic Disease, and the Institution of Translational Medicine in Cardiothoracic Diseases in Affiliated Hospital of Nantong University."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025